LINE vs CHE
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
LINE · Lineage$31.22 ▼ 3.64%
CHE · Chemed$548.59 ▼ 0.50%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- LINE +6.2%
- CHE +26.4%
Head to head
| Metric | LINE | CHE |
|---|---|---|
| Price | $31.22 | $548.59 |
| Change today | ▼ 3.64% | ▼ 0.50% |
| Market cap | $7.11B | $7.11B |
| Return, 3 months | -22.3% | +3.7% |
| Return, year to date | -6.8% | +28.7% |
| Return, 1 year | -3.4% | +27.4% |
| P/E (TTM) | – | 26.3 |
| P/B | 0.9 | 8.3 |
| P/E percentile vs own 5y | 56th | 31st |
| Dividend yield | 6.81% | 0.46% |
| Revenue growth (YoY, latest qtr) | -1.2% | +10.6% |
| Net profit growth (YoY) | -54.5% | +11.5% |
| Gross margin | 31.4% | 33.5% |
| Operating margin | 3.6% | 14.0% |
| Net margin | -4.2% | 10.6% |
| Return on equity | -2.8% | 29.1% |
| Analyst target vs. price | +31.6% | +11.6% |
| Analyst buy share | 27% | 60% |
| RSI (14) | 31 | 61 |
| 30-day volatility | 51.3% | 24.8% |
| Max drawdown, 1 year | -28.9% | -23.0% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- LINE is the largest of the group by market value.
- CHE has returned the most over the past year.
- LINE pays the highest dividend yield.
- CHE is growing revenue fastest.
- CHE keeps the most profit per dollar of sales.
- CHE has been the calmest stock over the last 30 days.